New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine

Código QR

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine

Bernhard T BauneDepartment of Psychiatry, School of Medicine, James Cook University, Queensland 4811, AustraliaAbstract: Quetiapine has demonstrated efficacy in schizophrenia, bipolar disorder and in the treatment of specific symptom clusters such as agitation and sleep problems in mood disorders. I...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Bernhard T Baune
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/a35e124403f84828acb784b59cbbb6cc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott J, et al.
Publicado: (2012)

Quetiapine monotherapy for bipolar depression
por: Michael E Thase
Publicado: (2008)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
por: Fontani V, et al.
Publicado: (2011)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Differential attentional bias in generalized anxiety disorder and panic disorder
por: Chen J, et al.
Publicado: (2013)

Duloxetine in the treatment of generalized anxiety disorder
por: Trevor R Norman, et al.
Publicado: (2009)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
por: Prasko J, et al.
Publicado: (2016)

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel A
Publicado: (2013)

Prevalence of Comorbid Anxiety Disorders and Their Associated Factors in Patients with Bipolar Disorder or Major Depressive Disorder
por: Inoue T, et al.
Publicado: (2020)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

The role of duloxetine in the treatment of anxiety disorders
por: Domenico De Berardis, et al.
Publicado: (2008)

Pregabalin for the treatment of generalized anxiety disorder: an update
por: Baldwin DS, et al.
Publicado: (2013)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Mazen K Ali, et al.
Publicado: (2011)

Augmentation treatment in major depressive disorder: focus on aripiprazole
por: J Craig Nelson, et al.
Publicado: (2008)

Mitochondrial dysfunction, oxidative stress, and major depressive disorder
por: Tobe EH
Publicado: (2013)

Levomilnacipran for the treatment of major depressive disorder: a review
por: Asnis GA, et al.
Publicado: (2015)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki A, et al.
Publicado: (2014)

Duloxetine for the treatment of generalized anxiety disorder: a review
por: Ahsan Y Khan, et al.
Publicado: (2008)

Major depressive disorder: mechanism-based prescribing for personalized medicine
por: Saltiel PF, et al.
Publicado: (2015)

Anatomical and functional brain abnormalities in unmedicated major depressive disorder
por: Yang X, et al.
Publicado: (2015)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang XF, et al.
Publicado: (2015)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez E, et al.
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan MN, et al.
Publicado: (2015)

A review of quetiapine in combination with antidepressant therapy in patients with depression
por: Ella J Daly, et al.
Publicado: (2007)

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Laura Gedge, et al.
Publicado: (2010)

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
por: Armaly Z, et al.
Publicado: (2012)

Getting the balance right: Established and emerging therapies for major depressive disorders
por: Bojana Perovic, et al.
Publicado: (2010)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
por: Zou C, et al.
Publicado: (2013)

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
por: Zhang L, et al.
Publicado: (2013)

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens J
Publicado: (2011)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran A, et al.
Publicado: (2013)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
por: Marty Hinz, et al.
Publicado: (2010)

Association between toll-like receptor 4 expression and symptoms of major depressive disorder
por: Wu MK, et al.
Publicado: (2015)

Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy
por: Demir S, et al.
Publicado: (2015)

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270
por: Yang Y, et al.
Publicado: (2015)

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder
por: Lai J, et al.
Publicado: (2017)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013)